Catalyst Wire Dossier Catalyst Wire Dossier

MILR1444A

· Genentech, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MILR1444A, covering 2010-05-06 to 2010-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma [Phase 2]

See pricing